Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 5/20 | 0.69 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.49 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | GSR | P00390 | 2/20 | 0.49 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | GRM8 | O00222 | 1/20 | 0.47 |
| ▸ | GRM6 | O15303 | 1/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.47 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7563962 | 1.00 | FOLH1 (0.69) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL170727 | 1.00 | FOLH1 (0.69) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL21330535 | 1.00 | FOLH1 (0.69) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL29371650 | 1.00 | FOLH1 (0.69) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL30394354 | 0.97 | FOLH1 (0.66) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL29617541 | 0.96 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL31665998 | 0.96 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL29988016 | 0.96 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL29534230 | 0.96 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP4GSR | |
| SCHEMBL30468678 | 0.96 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP4GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12582593-B2 | Oral care compositions for gum health | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | claimed |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-15 | — | — | US | claimed |
| EP-4110270-B1 | ORAL CARE COMPOSITIONS FOR GUM HEALTH | PROCTER & GAMBLE (US) | 2025-04-09 | — | — | EP | claimed |
| WO-2025072150-A1 | ZWITTERIONIC LIPID NANOPARTICLE COMPOSITIONS, AND METHODS OF USE | CORNELL UNIVERSITY (US) | 2025-04-03 | — | — | WO | claimed |
| US-20250064741-A1 | METHODS FOR ENHANCED NUCLEIC ACID DELIVERY | CORNELL UNIVERSITY (US) | 2025-02-27 | — | — | US | claimed |
| WO-2025029636-A2 | GLYCAN-CONTAINING DRUG DELIVERY SYSTEMS | CORNELL UNIVERSITY (US) | 2025-02-06 | — | — | WO | claimed |
| CN-119072299-A | Cosmetic composition containing retinoid, centella asiatica extract and dipeptide | 布茨公司 | 2024-12-03 | — | — | CN | claimed |
| US-20240307309-A1 | ZWITTERIONIC LIPID NANOPARTICLE COMPOSITIONS, AND METHODS OF USE | CORNELL UNIVERSITY | 2024-09-19 | — | — | US | claimed |
| CN-114949236-B | Disaccharide linker, disaccharide-small molecule drug conjugate, and sugar chain site-directed antibody-drug conjugate, and preparation method and application thereof | 中国科学院上海药物研究所 | 2024-09-06 | — | — | CN | claimed |
| EP-4392010-A1 | ORAL CARE COMPOSITIONS FOR GUM HEALTH | The Procter & Gamble Company (US) | 2024-07-03 | — | — | EP | claimed |
| US-20150065366-A1 | Biomarkers for Bladder Cancer and Methods Using the Same | METABOLON, INC. | 2015-03-05 | — | — | US | claimed |
| EP-2776832-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-09-17 | — | — | EP | claimed |
| WO-2013070839-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-05-16 | — | — | WO | claimed |
| US-8101162-B2 | Hair growth composition | AJINOMOTO CO., INC. (JP) | 2012-01-24 | — | — | US | claimed |
| US-20090131337-A1 | HAIR GROWTH COMPOSITION | AJINOMOTO CO. INC (JP) | 2009-05-21 | — | — | US | claimed |
| EP-2042157-A1 | HAIR GROWTH COMPOSITION | Ajinomoto Co., Inc. (JP) | 2009-04-01 | — | — | EP | claimed |
| CN-1842350-A | Crosslinked compositions comprising collagen and demineralized bone matrix | SDGI HOLDINGS INC (US) | 2006-10-04 | — | — | CN | claimed |
| US-6008256-A | COMPRISES (A) LIDOCAINE, (B) EPINEPHRINE IN SPECIFIC AMOUNT, AND (C) ONE OR MORE AMINO ACIDS; EXCELLENT STORAGE STABILITY | SHOWA YAKUHIN KAKO CO., LTD. (JP) | 1999-12-28 | — | — | US | claimed |
| EP-0858803-A1 | COMPOSITION FOR LOCAL ANESTHESIA | Showa Yakuhin Kako Co. Ltd (JP) | 1998-08-19 | — | — | EP | claimed |
| WO-1992000383-A1 | ANTIBODIES SPECIFIC FOR THE TRANSGLUTAMINASE-INDUCED ISOPEPTIDE BOND | CIS BIO INTERNATIONAL (FR) | 1992-01-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064741-A1 | METHODS FOR ENHANCED NUCLEIC ACID DELIVERY | CD14, MSR1, HNRNPAB | FOLH1 1555/4885DPP8 1289/4885DPP9 870/4885 |
| US-12582593-B2 | Oral care compositions for gum health | MAFK, HYPK, FGF2 | FOLH1 2233/4885DPP8 3722/4885DPP9 2420/4885 |
| US-20240307309-A1 | ZWITTERIONIC LIPID NANOPARTICLE COMPOSITIONS, AND METHODS OF USE | CETP, PHOSPHO1, SGMS1 | FOLH1 1576/4885DPP8 2555/4885DPP9 1426/4885 |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | RARA, RARG, RARB | FOLH1 288/4885DPP8 46/4885DPP9 53/4885 |
| US-20090131337-A1 | HAIR GROWTH COMPOSITION | FGF1, KRT18, NGF | FOLH1 47/4885DPP8 2983/4885DPP9 2862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.